These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
650 related items for PubMed ID: 30114411
1. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis. Bae CR, Hino J, Hosoda H, Miyazato M, Kangawa K. Life Sci; 2018 Sep 15; 209():349-356. PubMed ID: 30114411 [Abstract] [Full Text] [Related]
2. Vascular endothelial cell-specific overexpression of CNP did not improve liver fibrosis in HFFCD-induced NASH, but did improve renal lesions. Ensho T, Hino J, Ueda Y, Miyazato M, Iwakura H. Peptides; 2024 Feb 15; 172():171146. PubMed ID: 38157939 [Abstract] [Full Text] [Related]
3. Overexpression of C-type Natriuretic Peptide in Endothelial Cells Protects against Insulin Resistance and Inflammation during Diet-induced Obesity. Bae CR, Hino J, Hosoda H, Arai Y, Son C, Makino H, Tokudome T, Tomita T, Kimura T, Nojiri T, Hosoda K, Miyazato M, Kangawa K. Sci Rep; 2017 Aug 29; 7(1):9807. PubMed ID: 28852070 [Abstract] [Full Text] [Related]
4. Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats. Hayashizaki-Someya Y, Kurosaki E, Takasu T, Mitori H, Yamazaki S, Koide K, Takakura S. Eur J Pharmacol; 2015 May 05; 754():19-24. PubMed ID: 25701721 [Abstract] [Full Text] [Related]
5. Adipocyte-specific expression of C-type natriuretic peptide suppresses lipid metabolism and adipocyte hypertrophy in adipose tissues in mice fed high-fat diet. Bae CR, Hino J, Hosoda H, Son C, Makino H, Tokudome T, Tomita T, Hosoda K, Miyazato M, Kangawa K. Sci Rep; 2018 Feb 01; 8(1):2093. PubMed ID: 29391544 [Abstract] [Full Text] [Related]
6. Nicotinic alpha-7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non-alcoholic steatohepatitis. Kimura K, Inaba Y, Watanabe H, Matsukawa T, Matsumoto M, Inoue H. J Diabetes Investig; 2019 May 01; 10(3):659-666. PubMed ID: 30369082 [Abstract] [Full Text] [Related]
7. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice. Cai X, Fang C, Hayashi S, Hao S, Zhao M, Tsutsui H, Nishiguchi S, Sheng J. J Gastroenterol; 2016 Aug 01; 51(8):819-29. PubMed ID: 26794005 [Abstract] [Full Text] [Related]
8. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice. Motiño O, Agra N, Brea Contreras R, Domínguez-Moreno M, García-Monzón C, Vargas-Castrillón J, Carnovale CE, Boscá L, Casado M, Mayoral R, Valdecantos MP, Valverde ÁM, Francés DE, Martín-Sanz P. Biochim Biophys Acta; 2016 Sep 01; 1862(9):1710-23. PubMed ID: 27321932 [Abstract] [Full Text] [Related]
9. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis. Schumacher JD, Kong B, Pan Y, Zhan L, Sun R, Aa J, Rizzolo D, Richardson JR, Chen A, Goedken M, Aleksunes LM, Laskin DL, Guo GL. Toxicol Appl Pharmacol; 2017 Sep 01; 330():1-8. PubMed ID: 28673684 [Abstract] [Full Text] [Related]
10. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. Wei G, An P, Vaid KA, Nasser I, Huang P, Tan L, Zhao S, Schuppan D, Popov YV. Am J Physiol Gastrointest Liver Physiol; 2020 Jan 01; 318(1):G174-G188. PubMed ID: 31630534 [Abstract] [Full Text] [Related]
11. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis. Simon Y, Kessler SM, Gemperlein K, Bohle RM, Müller R, Haybaeck J, Kiemer AK. World J Gastroenterol; 2014 Dec 21; 20(47):17839-50. PubMed ID: 25548482 [Abstract] [Full Text] [Related]
12. Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis. Yoshimine Y, Uto H, Kumagai K, Mawatari S, Arima S, Ibusuki R, Mera K, Nosaki T, Kanmura S, Numata M, Tamai T, Moriuchi A, Tsubouchi H, Ido A. Oncol Rep; 2015 Apr 21; 33(4):1657-66. PubMed ID: 25607821 [Abstract] [Full Text] [Related]
13. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model. Nakanishi K, Kaji K, Kitade M, Kubo T, Furukawa M, Saikawa S, Shimozato N, Sato S, Seki K, Kawaratani H, Moriya K, Namisaki T, Yoshiji H. Int J Mol Sci; 2019 Jun 03; 20(11):. PubMed ID: 31163617 [Abstract] [Full Text] [Related]
14. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH). Hartimath SV, Boominathan R, Soh V, Cheng P, Deng X, Chong YC, Yong FF, Tan PW, Han W, Robins EG, Goggi JL. Contrast Media Mol Imaging; 2019 Jun 03; 2019():6298128. PubMed ID: 31866798 [Abstract] [Full Text] [Related]
15. Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet. Ibusuki R, Uto H, Arima S, Mawatari S, Setoguchi Y, Iwashita Y, Hashimoto S, Maeda T, Tanoue S, Kanmura S, Oketani M, Ido A, Tsubouchi H. Liver Int; 2013 Nov 03; 33(10):1549-56. PubMed ID: 23682724 [Abstract] [Full Text] [Related]
16. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model. Hayashida M, Hashimoto K, Ishikawa T, Miyamoto Y. Int J Exp Pathol; 2019 Apr 03; 100(2):72-82. PubMed ID: 30887659 [Abstract] [Full Text] [Related]
17. Brain-specific natriuretic peptide receptor-B deletion attenuates high-fat diet-induced visceral and hepatic lipid deposition in mice. Yamashita Y, Yamada-Goto N, Katsuura G, Ochi Y, Kanai Y, Miyazaki Y, Kuwahara K, Kanamoto N, Miura M, Yasoda A, Ohinata K, Inagaki N, Nakao K. Peptides; 2016 Jul 03; 81():38-50. PubMed ID: 27020246 [Abstract] [Full Text] [Related]
18. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation. Ganz M, Csak T, Szabo G. World J Gastroenterol; 2014 Jul 14; 20(26):8525-34. PubMed ID: 25024607 [Abstract] [Full Text] [Related]
19. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice. Zhou ST, Cui W, Kong L, Yang X. Curr Med Sci; 2022 Jun 14; 42(3):513-519. PubMed ID: 35451807 [Abstract] [Full Text] [Related]
20. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease. Li DJ, Liu J, Hua X, Fu H, Huang F, Fei YB, Lu WJ, Shen FM, Wang P. Metabolism; 2018 Feb 14; 79():52-63. PubMed ID: 29129819 [Abstract] [Full Text] [Related] Page: [Next] [New Search]